FDA Lovenox Ruling Key To Competition Claims: Judge
A federal judge has dismissed Amphastar Pharmaceuticals Inc.'s fourth set of counterclaims against Aventis Pharmaceuticals Inc., ruling that federal regulators must take final action on the generics company's bid to produce...To view the full article, register now.
Already a subscriber? Click here to view full article